Deutsche Bank
UBX

Deutsche Bank’s Unity Biotechnology UBX Stock Holding History

Deutsche Bank’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,816
Closed -$504K – 4414
2021
Q3 		$504K Sell
16,816
-8,981
-35% -$317K ﹤0.01% 3025
2021
Q2 		$1.2M Buy
25,797
+23,103
+858% +$1.11M ﹤0.01% 2662
2021
Q1 		$162K Buy
2,694
+45
+2% +$3.07K ﹤0.01% 3743
2020
Q4 		$139K Buy
2,649
+806
+44% +$38.9K ﹤0.01% 3661
2020
Q3 		$64K Buy
1,843
+29
+2% +$1.84K ﹤0.01% 3761
2020
Q2 		$157K Buy
1,814
+857
+90% +$63.5K ﹤0.01% 3245
2020
Q1 		$55K Sell
957
-57
-6% -$3.59K ﹤0.01% 3505
2019
Q4 		$73K Buy
1,014
+285
+39% +$20.1K ﹤0.01% 3742
2019
Q3 		$43K Sell
729
-77
-10% -$5.45K ﹤0.01% 4016
2019
Q2 		$75K Sell
806
-2,104
-72% -$179K ﹤0.01% 4343
2019
Q1 		$234K Buy
2,910
+52
+2% +$5.9K ﹤0.01% 3914
2018
Q4 		$464K Buy
2,858
+1,715
+150% +$228K ﹤0.01% 3387
2018
Q3 		$186K Buy
1,143
+175
+18% +$28.8K ﹤0.01% 4263
2018
Q2 		$145K Buy
+968
New +$142K ﹤0.01% 4416

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Deutsche Bank's UBX Position: Q4 2021 in Review

Deutsche Bank sold out of Unity Biotechnology (UBX) in Q4 2021, closing a stake of 16,816 shares — an estimated $504K sold.

Deutsche Bank first reported a position in UBX in Q2 2018 and held it in 14 quarters. The position peaked at $1.2M in Q2 2021. 71 funds tracked by Wall St. Rank hold UBX as of Q4 2021.

  • Deutsche Bank reported no remaining Unity Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Deutsche Bank sold 16,816 Unity Biotechnology shares in Q4 2021, an estimated $504K.
  • Deutsche Bank first reported a position in Unity Biotechnology in Q2 2018 and held it in 14 quarters.
  • Deutsche Bank's Unity Biotechnology position peaked at $1.2M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.